SAR 66.5
(-1.77%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 291.18 Million | 139.89 Million | 178.5 Million | 116.83 Million | 75.05 Million | 78.76 Million |
Net Income | 54.58 Million | 142.6 Million | 203.13 Million | 82.19 Million | -26.28 Million | -25.23 Million |
Depreciation & Amortization | 130.66 Million | 109.43 Million | 93.21 Million | 58.43 Million | 114.51 Million | 126.05 Million |
Deferred income taxes | -234.48 Million | -36.95 Million | - | - | - | - |
Stock-based compensation | 10.49 Million | 6.73 Million | - | - | - | - |
Change in working capital | 89.5 Million | -95.02 Million | -116.94 Million | -26.78 Million | -26.93 Million | -23.08 Million |
Other non-cash items | 240.41 Million | 13.09 Million | -902.85 Thousand | 2.99 Million | 13.76 Million | 1.03 Million |
Investing Cash Flow | -398.4 Million | -146.01 Million | -72.07 Million | -150.89 Million | -48.24 Million | -28.94 Million |
Investments in PPE | -398.71 Million | -146.01 Million | -72.07 Million | -150.89 Million | -48.24 Million | -28.94 Million |
Acquisitions | 312.52 Thousand | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 312.52 Thousand | - | - | - | - | - |
Financing Cash Flow | -163.23 Million | 312.79 Million | -66.87 Million | 16.98 Million | -6.07 Million | -50.63 Million |
Debt repayment | -97.29 Million | -121.51 Million | -81.34 Million | -44.96 Million | -18.94 Million | -72.78 Thousand |
Dividends payments | -64.79 Million | -167.89 Million | - | - | - | - |
Common Stock Repurchased | - | - | - | -57.09 Million | -22.15 Million | - |
Common Stock Issuance | - | 605.3 Million | - | - | - | - |
Other Financing Activities | -1.14 Million | -3.1 Million | 14.47 Million | 119.04 Million | -2.85 Million | -50.56 Million |
Accounts receivables | 33.77 Million | 19.22 Million | -99.71 Million | -53.28 Million | -13.4 Million | -8.02 Million |
Accounts payables | 19.33 Million | 8.9 Million | 1.49 Million | -8.76 Million | - | - |
Inventory | -15.76 Million | -11.52 Million | -8.41 Million | -761.44 Thousand | 10.59 Million | -18.64 Million |
Other working capital | 52.16 Million | -111.62 Million | -10.3 Million | 36.02 Million | -24.12 Million | 3.57 Million |
Cash at beginning of period | 381.39 Million | 74.71 Million | 35.16 Million | 52.24 Million | 31.51 Million | 32.32 Million |
Cash at end of period | 110.94 Million | 381.39 Million | 74.71 Million | 35.16 Million | 52.24 Million | 31.51 Million |
Capital Expenditure | -398.71 Million | -146.01 Million | -72.07 Million | -150.89 Million | -48.24 Million | -28.94 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -270.45 Million | 306.67 Million | 39.55 Million | -17.07 Million | 20.73 Million | -815.04 Thousand |
Free Cash Flow | -107.53 Million | -6.11 Million | 106.42 Million | -34.05 Million | 26.8 Million | 49.82 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 61.81 Million | 15.12 Million | 5.93 Million | 54.58 Million | 6.71 Million | 10.29 Million |
Depreciation & Amortization | 36.02 Million | 33.7 Million | 35.95 Million | 130.66 Million | 31.86 Million | 30.4 Million |
Deferred income taxes | - | - | -96.16 Million | -234.48 Million | -79.43 Thousand | - |
Stock-based compensation | 341.36 Thousand | 1.55 Million | 2.19 Million | 10.49 Million | 2.78 Million | 5.5 Million |
Change in working capital | -56.39 Million | 2.3 Million | 14.05 Million | 89.5 Million | 88.83 Million | 34.53 Million |
Other non-cash items | 128.23 Million | 76.67 Million | 99.32 Million | 240.41 Million | 889.89 Thousand | -22.01 Million |
Investing Cash Flow | -54.46 Million | -85.9 Million | -102.82 Million | -398.4 Million | -140.35 Million | -97.44 Million |
Investments in PPE | -54.46 Million | -85.9 Million | -103.14 Million | -398.71 Million | -140.35 Million | -97.44 Million |
Acquisitions | - | - | 312.52 Thousand | 312.52 Thousand | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -140.37 Million | -85.9 Million | 312.52 Thousand | 312.52 Thousand | - | - |
Financing Cash Flow | 12.99 Million | -69.51 Million | -50.34 Million | -163.23 Million | -129.58 Thousand | -112.26 Million |
Debt repayment | -2.15 Million | - | -50.3 Million | -97.29 Million | -524.57 Thousand | -47.51 Million |
Dividends payments | - | -57.48 Million | - | -64.79 Million | - | -64.79 Million |
Common Stock Repurchased | 11.2 Million | -12.02 Million | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 1.78 Million | -69.51 Million | -44.69 Thousand | -1.14 Million | 394.99 Thousand | 49.3 Thousand |
Accounts receivables | -74.7 Million | -19.35 Million | 10.27 Million | 33.77 Million | 1.8 Million | 18.38 Million |
Accounts payables | 18.12 Million | 18.17 Million | -31.39 Million | 19.33 Million | 53.3 Million | -5.42 Million |
Inventory | 4.69 Million | -1.2 Million | -933.75 Thousand | -15.76 Million | -6.39 Million | -704.6 Thousand |
Other working capital | -4.51 Million | 4.68 Million | 36.1 Million | 52.16 Million | 40.11 Million | 22.28 Million |
Cash at beginning of period | 13.52 Million | 110.94 Million | 202.81 Million | 381.39 Million | 212.28 Million | 368.78 Million |
Cash at end of period | 17.8 Million | 13.52 Million | 110.94 Million | 110.94 Million | 202.81 Million | 212.28 Million |
Capital Expenditure | -54.46 Million | -85.9 Million | -103.14 Million | -398.71 Million | -140.35 Million | -97.44 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 4.28 Million | -97.41 Million | -91.87 Million | -270.45 Million | -9.47 Million | -156.49 Million |
Free Cash Flow | -8.7 Million | -27.9 Million | -41.83 Million | -107.53 Million | -9.34 Million | -44.22 Million |
CU
SHLT
VIPULLTD
009680
XOMAO
DNA